Kanya Rajangam Senti Biosciences, Inc. (SNTI) insider trading activity
Kanya Rajangam is Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc.. Currently has a direct ownership of 86,984 shares of SNTI, which is worth approximately $280,088. The most recent transaction as insider was on Mar 07, 2025, when has been sold 78,363 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
87K
13.88%
3M change
13.88%
12M change
Total Value Held
$280,088
Kanya Rajangam Transaction History
Also insider at
KR
Kanya Rajangam
Pres. & Chief Med. & Dev. Off.
South San Francisco, CA